Rahaf M. Altahan: Diagnosis and Management of Factor XIII Deficiency
Rahaf M. Altahan, Consultant Hematopathologist at King Fahad Medical City – KFMC, shared a post on LinkedIn:
“I am delighted to share that my paper on Factor XIII deficiency has been published in Frontiers-Medicine FXIIID is up to 10x more prevalent in countries with high rates of consanguinity. Yet it is frequently missed!
Routine coagulation screening cannot detect low FXIII levels, since it acts downstream in the clotting cascade, after the clot is already formed.
Compounding this, relatively low FXIII levels can still maintain adequate hemostasis, which can delay recognition. Together, these factors make FXIIID one of the most underdiagnosed bleeding disorders in clinical practice.
The review covers the epidemiology, molecular biology, and diagnostic strategies (and their pitfalls), along with management approaches, including special clinical scenarios such as pregnancy, neonatal care, surgery, and anticoagulation.
I hope this serves as a useful resource for hematologists, hematopathologists, laboratory specialists, and clinicians who may encounter this often-overlooked condition.”

Stay updated with Hemostasis Today.
-
Aug 25, 2026, 14:32Soumya Das: AIIMS Nagpur Celebrates World Apheresis Awareness Day 2026
-
Aug 25, 2026, 14:31Vidyashri Hattigoudar: Essentials and Management of Hemophilia A
-
Aug 25, 2026, 14:22Kavya Keerthana: ASH 2026 Guidelines for Immune Thrombocytopenia
-
Aug 25, 2026, 14:02Innocent Mupunga: Sri Lanka Strengthens Blood Screening Quality Through International Collaboration
-
Aug 25, 2026, 14:00Mohamed Tawengi: Balancing Bleeding and Coronary Thrombosis in STEMI With ITP
-
Aug 25, 2026, 13:55Rodrigo Assar: Modeling and Simulation to Improve Thrombosis and Hemostasis Care
-
Aug 25, 2026, 13:47Ruchi Punamia: Building Stronger Foundations in Immunohematology
-
Aug 25, 2026, 13:46Owen McCarty: How Infection Activates Coagulation Through Factor XII
-
Aug 25, 2026, 13:30Danny Hsu: AIMS 2026 to Spotlight Differential Diagnosis of Thrombotic Microangiopathy